● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
● The company's profit outlook over the next few years is a strong asset.
● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.65 for the 2024 fiscal year.
● For several months, analysts have been revising their EPS estimates roughly upwards.
● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
● The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
● The company does not generate enough profits, which is an alarming weak point.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 42.74 times its estimated earnings per share for the ongoing year.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
